\n\t\t\t\n\t\t\t\tLincoln National Corporation\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tAccording to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements, as well as failed to disclose material adverse facts about Lincoln<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tLincoln National Corporation\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tAccording to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements, as well as failed to disclose material adverse facts about Lincoln<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tHarbor Diversified, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tOn March 29, 2024, Harbor Diversified filed a current report on Form 8-K with the U.S. Securities and Exchange Commission. In this current report, Harbor<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tHarbor Diversified, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tOn March 29, 2024, Harbor Diversified filed a current report on Form 8-K with the U.S. Securities and Exchange Commission. In this current report, Harbor<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tReviva Pharmaceuticals Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tOn April 15, 2024, Reviva Pharmaceuticals filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that “the<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tReviva Pharmaceuticals Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tOn April 15, 2024, Reviva Pharmaceuticals filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that “the<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tCidara Therapeutics, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tOn April 16, 2024, Cidara Therapeutics filed a current report on Form 8-K with the SEC. In this 8-K, Cidara Therapeutics announced that it’s “previously<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tCidara Therapeutics, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tOn April 16, 2024, Cidara Therapeutics filed a current report on Form 8-K with the SEC. In this 8-K, Cidara Therapeutics announced that it’s “previously<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tGoodRx Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tAccording to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: while Kroger accounted for less than<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t\n\t\t\t\t\n\t\t\t\t\n\t\t\t\n\t\t\t\tGoodRx Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t\n\t\t\tAccording to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: while Kroger accounted for less than<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<\/div>\n\t\t\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\t
According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements, as well as failed to disclose material adverse facts about Lincoln<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements, as well as failed to disclose material adverse facts about Lincoln<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t On March 29, 2024, Harbor Diversified filed a current report on Form 8-K with the U.S. Securities and Exchange Commission. In this current report, Harbor<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t On March 29, 2024, Harbor Diversified filed a current report on Form 8-K with the U.S. Securities and Exchange Commission. In this current report, Harbor<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t On April 15, 2024, Reviva Pharmaceuticals filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that “the<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t On April 15, 2024, Reviva Pharmaceuticals filed with the SEC a current report on Form 8-K. In this current report, Reviva Pharmaceuticals announced that “the<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t On April 16, 2024, Cidara Therapeutics filed a current report on Form 8-K with the SEC. In this 8-K, Cidara Therapeutics announced that it’s “previously<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t On April 16, 2024, Cidara Therapeutics filed a current report on Form 8-K with the SEC. In this 8-K, Cidara Therapeutics announced that it’s “previously<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: while Kroger accounted for less than<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t According to the lawsuit, defendants throughout the Class Period made false and\/or misleading statements and\/or failed to disclose that: while Kroger accounted for less than<\/p>\n\t\t<\/div>\n\t\t\n\t\t\n\t\t\tRead More\t\t<\/a>\n\n\t\t\t\t<\/div>\n\t\t\t\t<\/article>\n\t\t\t\t<\/div>\n\t\t\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\n\t\t\t\n\t\t\t\tLincoln National Corporation\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tHarbor Diversified, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tHarbor Diversified, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tReviva Pharmaceuticals Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tReviva Pharmaceuticals Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tCidara Therapeutics, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tCidara Therapeutics, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tGoodRx Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t
\n\t\t\t\n\t\t\t\tGoodRx Holdings, Inc.\t\t\t<\/a>\n\t\t<\/h4>\n\t\t\t\t